Disruption of prepulse inhibition of acoustic startle as an animal model for schizophrenia

Japanese Journal of Psychopharmacology

Volumn 20, Issue 4, 2000, Pages 131-139

  Yamada, S ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Dopamine; Glutamate; Prepulse inhibition; Schizophrenia; Serotonin

Indexed keywords

2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; AMOXAPINE; APOMORPHINE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; HALOPERIDOL; KETANSERIN; MDL 28618A; MUSCIMOL; NEUROLEPTIC AGENT; NITRIC OXIDE SYNTHASE INHIBITOR; OLANZAPINE; PHENCYCLIDINE; PIPAMPERONE; PSYCHEDELIC AGENT; QUETIAPINE; RACLOPRIDE; RISPERIDONE; SEROTONIN; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUDITORY STIMULATION; BINDING AFFINITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FOREBRAIN; GLOBUS PALLIDUS; HUMAN; LIMBIC CORTEX; NONHUMAN; NUCLEUS ACCUMBENS; PREPULSE INHIBITION; RAT; REVIEW; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; BIOGENIC MONOAMINES; BRAIN; DISEASE MODELS, ANIMAL; GAIT DISORDERS, NEUROLOGIC; HUMANS; NEURAL INHIBITION; NEUROTRANSMITTER AGENTS; RECEPTORS, BIOGENIC AMINE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STARTLE REACTION;

EID: 0034523677     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Strain and age differences in acoustic startle responses and effects of nicotine in rats
2. Normalization of auditory physiology by cigarette smoking in schizophrenic patients
3. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine
4. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response
5. Prestimulus effects on human startle reflex in normals and schizophrenics
6. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients
7. The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the rat
8. Carbachol infusion into the dentate gyrus disrupts sensorimotor gating of startle in the rat
9. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat
10. A subcortical neurotransmitter imbalance syndrom?
11. Lack of sensitization to the effects of d-amphetamine and apomorphine on sensorimotor gating in rats
12. 5-HT1B receptor modulation of prepulse inhibition: Recent findings in wild-type and 5-HT1B knockout mice
13. The effects of an early stressful life event on sensorimotor gating in adult rats
14. An animal model of attention deficit
15. Competitive NMDA and strychnine-insensitive glycine site antagonists disrupt prepulse inhibition
16. Differential effects of the strychnine-insensitive glycine site antagonist (+)-HA-966 on the hyperactivity and the disruption of prepulse inhibition induced by phencyclidine in rats
17. Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice
18. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin subtype selective antagonists in mice
19. The more or less startling effects of weak prestimulation
20. Localizing haloperidol effects on sensorimotor gating in a predictive model of antipsychotic potency
21. Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis
22. Acoustic and temporal factors in the evocation of startle
23. The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801
24. Effects of phencyclidine metabolites on serotonin uptake in rat brain
25. Prepulse inhibits startle-induced reductions of extracellular dopamine in the nucleus accumbens of rat
26. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat
27. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: Effects of antipsychotics and other agents in rats
28. 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats
29. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle
30. Induction of Fos-protein in the forebrain and disruption of sensorimotor gating following N-methyl-D-aspartate infusion into the ventral hippocampus of the rat
31. Ventral pallidal GABA-A receptors regulate prepulse inhibition of acoustic startle
32. Reduced prepulse inhibition after electrolytic lesions of nucleus accumbens subregions in the rat
33. Regulation of prepulse inhibition by ventral pallidal projections
34. Role of the strychnine-insensitive glycine binding site in the nucleus accumbens and anterodorsal striatum in sensorimotor gating: A behavioral and microdialysis study
35. ACEA 1021, a glycine site antagonist with minor psychotomimetic and amnestic effects in rats
36. m-chlorophenylpiperadine (MCPP) effects in nuroleptic-free schizophrenic patients
37. Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers
38. Effect of acute subcutaneus nicotine on prepulse inhibition of the acoustic startle reflex in healthy male non-smokers
39. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat
40. Neonatal excitotoxic hippocampal damage in rats caused post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine
41. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats
42. Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition
43. Adverse effects of fenfluramine in treatment refractory schizophrenia
44. Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors
45. Serotonergic involvement in phencyclidine-induced behaviors
46. Phencyclidine-induced head-twitch response as 5-HT2 receptor-mediated behavior in rats
47. Prestimulation-induced startle modulation in attention deficit hyperactivity disorder and nocturnal enuresis
48. 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats
49. Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats
50. Prenatal exposure to nicotine: Effects on prepulse inhibition and central nicotinic receptors
51. The role of serotonin in schizophrenia
52. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats
53. DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum
54. Rats reared in social isolation show schizophrenia-like changes in auditory gating
55. Effect of spiperone, raclopride, SCH23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat
56. Assesing the validity of an animal model of deficit sensorimotor gating in schizophrenic patients
57. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease
58. Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats
59. Seroquel restores sensorimotor gating in phencyclidine-treated rats
60. Reversal of dizocilpine-induced disruption of prepulse inhibition of an acoustic startle response by the 5-HT 2 receptor antagonist ketanserin
61. Examination of drug-induced and isolation-induced disruption of prepulse inhibition as models to screen antipsychotic drugs
62. The basolateral amygdala regulates sensorimotor gating of acoustic startle in the rat
63. Presynaptic dopamine-glutamate interaction in the nucleus accumbens regulate sensorimotor gating
64. The ventral subiculum modulation of prepulse inhibition is not mediated via dopamine D2 or nucleus accumbens non-NMDA glutamate receptor activity
65. Antipsychotic like effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats
66. Dopamine autoreceptors in rat nucleus accumbens modulate prepulse inhibition of acoustic startle
67. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats
68. Phencyclidine-induced head-weaving and head-twitch through interaction with 5-HT1 and 5-HT2 receptors in reserpinized rats
69. Startle and sensorimtor correlates of ventral thalamic dopamine and GABA in rodents
70. Repeated administration of amphetamine induces sensitization to its disruptive effect on prepulse inhibition in rat